162 related articles for article (PubMed ID: 2894488)
1. Terazosin: a new long-acting alpha 1-adrenergic antagonist for hypertension.
Frishman WH; Eisen G; Lapsker J
Med Clin North Am; 1988 Mar; 72(2):441-8. PubMed ID: 2894488
[TBL] [Abstract][Full Text] [Related]
2. Terazosin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in essential hypertension.
Titmarsh S; Monk JP
Drugs; 1987 May; 33(5):461-77. PubMed ID: 2885169
[TBL] [Abstract][Full Text] [Related]
3. Terazosin: a new alpha adrenoceptor blocking drug.
Achari R; Laddu A
J Clin Pharmacol; 1992 Jun; 32(6):520-3. PubMed ID: 1353083
[TBL] [Abstract][Full Text] [Related]
4. Terazosin: pharmacokinetics and the effect of age and dose on the incidence of adverse events.
Somberg JC; Achari R; Laddu AR
Am Heart J; 1991 Sep; 122(3 Pt 2):901-5. PubMed ID: 1678920
[TBL] [Abstract][Full Text] [Related]
5. Terazosin: a new antihypertensive agent with favorable effects on lipids.
Luther RR
Int J Clin Pharmacol Ther Toxicol; 1989 Jul; 27(7):313-9. PubMed ID: 2570758
[TBL] [Abstract][Full Text] [Related]
6. Alpha-adrenergic receptor blockade with prazosin. Consideration of hypertension, heart failure, and potential new applications.
Colucci WS
Ann Intern Med; 1982 Jul; 97(1):67-77. PubMed ID: 6124197
[TBL] [Abstract][Full Text] [Related]
7. Antihypertensive effects of doxazosin in systemic hypertension and comparison with terazosin.
Hayduk K; Schneider HT
Am J Cardiol; 1987 May; 59(14):95G-98G. PubMed ID: 2884860
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of terazosin.
Sonders RC
Am J Med; 1986 May; 80(5B):20-4. PubMed ID: 2872802
[TBL] [Abstract][Full Text] [Related]
9. Alpha 2-agonist versus alpha 1-antagonist in mild-to-moderate hypertension: comparison of transdermal clonidine and terazosin monotherapies.
Harris SI; Alvarez C
Am J Ther; 1997 Jan; 4(1):9-15. PubMed ID: 10423584
[TBL] [Abstract][Full Text] [Related]
10. Terazosin: a new alpha 1-blocker for the treatment of hypertension: a review of randomized, controlled clinical trials of once-daily administration as monotherapy.
Luther RR; Glassman HN; Sperzel WD; Steinberg FJ; Horton JK; Jordan DC
J Hypertens Suppl; 1986 Dec; 4(5):S494-7. PubMed ID: 2883273
[TBL] [Abstract][Full Text] [Related]
11. Terazosin for hypertension.
Med Lett Drugs Ther; 1987 Dec; 29(755):112-3. PubMed ID: 2891021
[No Abstract] [Full Text] [Related]
12. Long-term efficacy and safety of terazosin.
Cohen J
J Clin Pharmacol; 1993 Mar; 33(3):272-8. PubMed ID: 8096524
[No Abstract] [Full Text] [Related]
13. Long-term efficacy and safety of terazosin alone and in combination with other antihypertensive agents.
Cohen JD
Am Heart J; 1991 Sep; 122(3 Pt 2):919-25. PubMed ID: 1678923
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of terazosin in the treatment of essential hypertension in blacks.
Luther RR; Klepper MJ; Maurath CJ; Glassman HN; Achari R; Laddu AR
J Hum Hypertens; 1990 Apr; 4(2):151-3. PubMed ID: 1971027
[TBL] [Abstract][Full Text] [Related]
15. Terazosin, a new selective alpha 1-adrenergic blocking agent. Results of long-term treatment in patients with essential hypertension.
Luther RR; Glassman HN; Estep CB; Schmitz PJ; Horton JK; Jordan DC
Am J Hypertens; 1988 Jul; 1(3 Pt 3):237S-240S. PubMed ID: 2901267
[TBL] [Abstract][Full Text] [Related]
16. The safety and efficacy of terazosin in the treatment of essential hypertension in blacks.
Saunders E
Am Heart J; 1991 Sep; 122(3 Pt 2):936-42. PubMed ID: 1678925
[TBL] [Abstract][Full Text] [Related]
17. [Terazosin].
Schäfers RF; Michel MC
Dtsch Med Wochenschr; 1998 Apr; 123(15):459-60. PubMed ID: 9581161
[No Abstract] [Full Text] [Related]
18. Effects of oral and intravenous terazosin and head-up tilt on blood pressure responses in patients with hypertension.
Achari R; Hosmane B; Linnen P; Cavanaugh J; Baroldi P; Cohen A
J Clin Pharmacol; 1998 Jun; 38(6):545-53. PubMed ID: 9650545
[TBL] [Abstract][Full Text] [Related]
19. Safety assessment of terazosin in the treatment of patients with symptomatic benign prostatic hyperplasia: a combined analysis.
Lowe FC
Urology; 1994 Jul; 44(1):46-51. PubMed ID: 7518981
[TBL] [Abstract][Full Text] [Related]
20. Alpha 1-blockade for the treatment of hypertension: a megastudy of terazosin in 2214 clinical practice settings.
Itskovitz HD
Clin Ther; 1994; 16(3):490-504. PubMed ID: 7923316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
